TTP607 in Refractory Solid Malignancies

NCT00939172 · clinicaltrials.gov ↗

PHASE1

Phase

WITHDRAWN

Status

OTHER

Sponsor class

Conditions

Advanced Cancers
Lymphoma

Interventions

DRUG: TTP607

Sponsor

M.D. Anderson Cancer Center

Collaborators

[object Object]